The Two Chambers by Pedro Puech5/26/2023 ![]() ![]() ![]() ![]() Modern drug therapy can also reduce stroke rates but even with it, patients with severe carotid stenosis might have a risk of about 1% per year of disabling stroke or death. There is also some procedural risk of non-disabling stroke (particularly with CAS) or of non-fatal myocardial infarction or cranial nerve palsy (particularly with CEA). The procedural risks have decreased over the decades, but there is still about a 1% risk of disabling stroke or death. In patients with severe carotid artery stenosis, carotid artery stenting (CAS) and carotid endarterectomy (CEA) both carry procedural risks, which are about twice as great for symptomatic as for asymptomatic patients, but they can restore patency and approximately halve long-term stroke rates in asymptomatic patients. The Lancet Regional Health – Western Pacific.The Lancet Regional Health – Southeast Asia.The Lancet Gastroenterology & Hepatology. ![]()
0 Comments
Leave a Reply. |